1 Trial profile. cell-mediated immunity and cytokine systems, which were evaluated using stream cytometry, LUMINEX and ELISpot assay. Results: Immunization with rVSV-ZEBOV was well tolerated without critical vaccine-related adverse occasions. Ebola virus-specific neutralizing antibodies were induced in every people nearly. Additionally, vaccinees, within the best dosage cohort especially, generated Ebola Continue Reading